Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Heart disease trial tests power of cellular antioxidant

NCT ID NCT05410873

Summary

This study tested whether a supplement called MitoQ could improve heart function in people with dilated cardiomyopathy, a condition where the heart muscle is weakened. Over 100 participants were randomly assigned to receive either MitoQ or a placebo for several months. Researchers used heart scans and blood tests to see if reducing cellular stress could help the heart work better.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DILATED CARDIOMYOPATHY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Royal Brompton Hospital

    London, United Kingdom

Conditions

Explore the condition pages connected to this study.